Envveno Medical Corporation

CUSIP 29415J205COM NEWQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

5.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Feb 20, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 20, 2026	Braeden Lichti	13D	5.0%	—	SEC
2	Feb 20, 2026	Northstrive Fund II LP	13D	5.0%	—	SEC
3	Feb 10, 2026	Northstrive Fund II LP	13G	5.0%	33.2K	SEC
4	Feb 10, 2026	Braeden Lichti	13G	5.0%	33.2K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Kingdon Capital Management, L.L.C.	36.2K	$366.4K
2	Cm Management, LLC	35.7K	$361.8K
3	Geode Capital Management, LLC	10.5K	$105.9K
4	Jpmorgan Chase & Co	5.2K	$52.9K
5	Blackrock, Inc.	1.8K	$18.6K
6	Westside Investment Management, Inc.	1.6K	$16.1K
7	Tower Research Capital LLC (Trc)	542	$5.5K
8	Ubs Group AG	243	$2.5K
9	Wells Fargo & Company/Mn	114	$1.2K
10	Morgan Stanley	76	$770